The latest gynaecological cancer news
GSK plc announced today that the European Commission has approved dostarlimab in combination with chemotherapy…
Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm…
A landmark event bringing together health leaders, policymakers, researchers, and advocates from Albania, Bosnia and…
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical…
A recent study led by researchers at the University of Arizona Cancer Center and Northern Arizona…
Leading experts have warned that, despite the use of new technologies like HPV self-collection in selected…
Researchers at the Icahn School of Medicine at Mount Sinai, USA, have discovered a way…
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumours use to cripple immune…
A joint research team led by Professor Hyun-Woong Cho (Department of Obstetrics and Gynecology) and…
Most uterine cancers have excellent five-year survival rates – up to 95% for localised cancer.…